ARCON: accelerated radiotherapy with carbogen and nicotinamide in non small cell lung cancer: a phase I/II study by the EORTC.
about
Effect of a topical vasodilator on tumor hypoxia and tumor oxygen guided radiotherapy using EPR oximetryVascular disrupting agent arsenic trioxide enhances thermoradiotherapy of solid tumors.Acute Tumor Lactate Perturbations as a Biomarker of Genotoxic Stress: Development of a Biochemical Model.Effects of nicotinamide and carbogen on tumour oxygenation, blood flow, energetics and blood glucose levels.Synergistic combination of hyperoxygenation and radiotherapy by repeated assessments of tumor pO2 with EPR oximetry.Kinetic modeling in PET imaging of hypoxia.Hyperthermic enhancement of tumor radiosensitization strategies.In vivo measurement of regional oxygenation and imaging of redox status in RIF-1 murine tumor: effect of carbogen-breathing.Targeting Hypoxia to Improve Non-Small Cell Lung Cancer Outcome.Modified oxygen mask to induce target levels of hyperoxia and hypercarbia during radiotherapy: a more effective alternative to carbogen.
P2860
Q33882791-39F6A82F-41E5-4A2C-BD64-143C407AE9AFQ35681405-5BAC4336-234C-481D-9EC6-2BF189AE7E78Q36603161-81E1EE80-0439-477F-A2A7-84A140E3C51EQ36620994-37404083-3373-47A5-A8B1-D711A11D8CB2Q37639982-D6816992-1195-4FDD-8C0B-6B6A575292CAQ38253648-AA1D3FF2-7E09-4CE7-AC74-A239A0818E6DQ40379003-10293037-2659-470D-A54E-5A57EB7F0583Q44157559-D81E4BAE-1B13-450B-9B73-B20D23E91D5AQ47769995-5ABE7230-67BA-4809-9C0E-DEBBDDC98DAAQ50991675-A201E151-68D2-4D9E-BE42-9A77E9CC8756
P2860
ARCON: accelerated radiotherapy with carbogen and nicotinamide in non small cell lung cancer: a phase I/II study by the EORTC.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
ARCON: accelerated radiotherap ...... phase I/II study by the EORTC.
@en
type
label
ARCON: accelerated radiotherap ...... phase I/II study by the EORTC.
@en
prefLabel
ARCON: accelerated radiotherap ...... phase I/II study by the EORTC.
@en
P2093
P1476
ARCON: accelerated radiotherap ...... phase I/II study by the EORTC.
@en
P2093
Antognoni P
Denekamp J
Kaanders J
P304
P356
10.1016/S0167-8140(99)00106-1
P50
P577
1999-08-01T00:00:00Z